Search

Filters
Clear All
  • 12
  • 44
  • 554

Phase

  • 11
  • 14
  • 54
  • 8
  • 65
  • 4
  • 451
  • 538
  • 262
  • 606
  • 4

Found 610 iu-health-enterprise-system trials

A listing of iu-health-enterprise-system medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

N
Naga Chalasani, MD
18 years - 85 years
All genders
What is this study about?The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or patients with chronic hepatitis B infection. Eligible patients will be randomized in a 1:1 fashion to Arm A using …
E
Erin Weber
18 years - 100 years
All genders
Observational
What is this study about?The purpose of this study is to measure outcomes related to close-range and long-range gunshot wounds to the hand, wrist, and arm.   THIS STUDY IS ENROLLING BY INVITATION ONLY - Patients will be identified and recruited by Dr. Weber and other hand surgeons providing care for the …
B
Benjamin Landis, MD
1 year - 100 years
All genders
Observational
What is this study about?Coarctation of the aorta (CoA) tissues contain distinctive cell populations, and comprehensive analysis of these cells will provide understanding of cell abnormalities that are driving CoA. We want to define these types of cells that are abnormally located in the diseased aortic tissues of neonates with …
S
Scott Coven
39 years or below
All genders
What is the purpose of this study?To longitudinally assess cognitive outcomes using an a neurocognitive screening battery in children and young adults diagnosed with a CNS tumor. To longitudinally assess the impact of specific therapies on the QOL in children and young adults diagnosed with a CNS tumor.To longitudinally assess …
J
Jodi Skiles
1 years - 39 years
All genders
Phase 1
What is the purpose of this study?A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and young adults (CAYA) with high risk T-cell acute lymphoblastic leukemia (T-ALL) or …
N
Namita Agrawal
18 years or above
Female
Interventional
This study investigates the feasibility of adding pre-rehabilitation pelvic health physical therapy to the standard radiation treatment plan for women with certain types of cancer. These include cervical, vaginal, vulvar, uterine, or anal cancer. Participants will receive education on using a vaginal dilator during their treatment. The study will also …
D
Donna Wilcock
100 years or below
All genders
Observational
What is the purpose of this study?The goal of this research is to create a repository of brain imaging and biological samples to study individuals undergoing clinical treatment with anti-amyloid therapies and compare them with samples and images from healthy individuals and cognitively impaired individuals not receiving these treatments. We …
M
Mark Dillon
18 years - 100 years
All genders
Observational
What is the purpose of this study?This study is an ongoing, non-randomized, multi-center, prospective registry utilizing primary or revision shoulder arthroplasty implants.  Subjects will be treated according to standard of care at each center. The objective of the study is a multi-center prospective registry to collect clinical outcomes of anatomic …
I
Ivan Hadad
18 years - 100 years
All genders
Interventional
What is the purpose of this study?This study will investigate the utility of Silk bioprotein, an FDA-approved and readily available post-surgical dressing, as a wound dressing for patients undergoing double-incision mastectomy for female-to-male gender affirmation surgery.THIS STUDY IS ENROLLING BY INVITATION ONLY - Patients will be those who are already …
R
Rohan Maniar
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC …
511 - 520 of 610